Related Experiment Video
Updated: Oct 1, 2025
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.1K
Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials
Liwen Su1, Xin Chen1, Jingyi Zhang1
1Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
JCO Precision Oncology
|March 9, 2022
Summary
Bayesian information borrowing enhances oncology clinical trial efficiency. Choosing the right method, like Bayesian hierarchical models for concurrent data or informative priors for nonconcurrent data, is crucial for optimal trial design performance.
Area of Science:
- Oncology
- Clinical Trial Design
- Biostatistics
Background:
- Precision medicine drives innovative oncology trial designs for novel antitumor drugs.
- Bayesian information borrowing is key to improving clinical trial efficiency by incorporating external data.
- Selecting appropriate Bayesian methods is critical for complex oncology trials.
Purpose of the Study:
- To categorize Bayesian information borrowing scenarios into concurrent and nonconcurrent.
- To review existing methods for each scenario.
- To compare method performance regarding type I error and power.
Main Methods:
- Divided borrowing scenarios into concurrent (simultaneous data) and nonconcurrent (non-simultaneous data).
- Overviewed Bayesian methods applicable to each scenario.
- Conducted simulations to compare method performance (Type I error, power).
Main Results:
- Bayesian hierarchical models are suitable for concurrent borrowing, especially with homogeneous arms.
- Caution is advised for Bayesian hierarchical models with heterogeneous arms; alternative methods are recommended.
- Informative priors are suggested for nonconcurrent borrowing; multisource exchangeability models for multiple historical trials.
- Meta-analytic-predictive priors require careful application.
Conclusions:
- Bayesian information borrowing significantly improves oncology clinical trial efficiency.
- Careful selection of the appropriate borrowing method is essential for achieving ideal design performance in innovative oncology trials.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
187
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
187
01:24Kaplan-Meier Approach
290
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
290
01:21Cancer Survival Analysis
472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
01:20Comparing the Survival Analysis of Two or More Groups
323
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
323
01:12Hazard Ratio
278
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
278
01:26Pharmacokinetic Models: Comparison and Selection Criterion
163
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
163